logo

For the Inventor, By the Inventor

Rilly la Montagne, France

Frederic H Jung

This inventor holds 33 USPTO granted patents, primarily in Pharmaceutical Chemistry. Top assignees: Ici Pharma, Astrazeneca Ab, Imperial Chemical Industries Limited. Active years: 1984-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederic H Jung. Retrieved from https://idiyas.com/inventor/frederic-h-jung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 33

% Patents Active = 78.8

Average Co-Inventor Count = 1.9

ph-index = 6

Forward Citations = 171(Granted Patents)


Location History:

  • Rilly la Montague, FR (1985)
  • le Moulin Cliguot, FR (1987)
  • Rillay la Montagne, FR (1995)
  • Rilly la Montagne, FR (1984 - 1996)
  • Reims Cedex 2, FR (2010)
  • Reims, FR (1984 - 2015)
  • Macclesfield, GB (2017)

Company Filing History:

goldMedal17 out of 80 
 
Ici Pharma
 patents
silverMedal10 out of 1,534 
 
Astrazeneca Ab
 patents
bronzeMedal6 out of 3,840 
 
Imperial Chemical Industries Limited
 patents
4. 6 out of 854 
 
Zeneca Limited
 patents
where one patent can have more than one assignee

Years Active: 1984-2017

Loading Chart...
Areas of Expertise:
Quinazoline Derivatives
Antibiotic Compounds
Cephalosporins
Aurora Kinase Inhibitors
Pharmaceutical Use
Carbapenem Compounds
Chemical Compounds
Substituted Derivatives
33 patents (USPTO):Explore Patents
1. 9567358 - Methods of treatment using N-(3-fluorophenyl)-2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}acetamide (2017-02-14),
2. 9018191 - Phosphonoxy quinazoline derivatives and their pharmaceutical use (2015-04-28),
3. 8268841 - Phosphonoxy quinazoline derivatives and their pharmaceutical use (2012-09-18),
4. 8153643 - Quinazoline derivatives (2012-04-10),
5. 7973164 - Quinoline derivatives (2011-07-05),
6. 7709479 - Quinazoline derivatives and their use as pharmaceuticals (2010-05-04),
7. 7691867 - Chemical compounds (2010-04-06),
8. 7402585 - Substituted quinazoline derivatives as inhibitors of aurora kinases (2008-07-22),
9. 6977259 - Quinoline derivatives and their use as aurora 2 kinase inhibitors (2005-12-20),
10. 6919338 - Substituted quinazoline derivatives and their use as inhibitors of aurora-2 kinase (2005-07-19),
11. 5571805 - Antibiotic compounds (1996-11-05),
12. 5527793 - Antibiotic carbapenem compounds (1996-06-18),
13. 5527791 - Carbapenem antibiotic compounds (1996-06-18),
14. 5519015 - Carbapenem antibiotic compounds (1996-05-21),
15. 5444057 - Carbapenem-antibiotic compounds (1995-08-22),

Title: Inventor Frederic H Jung: Pioneering Innovations in Rilly la Montagne

Introduction: Frederic H Jung is a renowned inventor hailing from Rilly la Montagne, France, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Frederic H Jung holds several patents in various technological domains, including artificial intelligence, renewable energy, and medical devices, showcasing his versatility and ingenuity in inventing cutting-edge solutions.

Career Highlights: Throughout his illustrious career, Frederic H Jung has worked with leading research institutions and technology companies, spearheading projects that have revolutionized industries and improved the quality of life for many.

Collaborations: Frederic H Jung has collaborated with top engineers, scientists, and designers from around the world, fostering a culture of innovation and excellence in all his projects. His collaborative spirit has led to the development of groundbreaking technologies that have received international acclaim.

Conclusion: In conclusion, Frederic H Jung's passion for innovation, coupled with his relentless pursuit of excellence, has solidified his reputation as a visionary inventor in Rilly la Montagne and beyond. His contributions to the world of technology continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…